Financing ·
Smith & Nephew plc completed the pricing of a USD 700 million issuance of 5.750% Notes due in 2036, receiving net…
SNNSmith & Nephew PLC
Smith & Nephew plc completed the pricing of a USD 700 million issuance of 5.750% Notes due in 2036, receiving net proceeds of approximately USD 690.9 million after underwriting discounts. The company intends to use these funds primarily to finance the purchase of its outstanding 2.032% Senior Notes due in 2030 through a tender offer and to cover related fees and expenses, with any remaining balance allocated for general corporate purposes. The transaction is scheduled to close on September 11, 2026, subject to customary conditions. Smith & Nephew operates as a global medical technology company focused on the repair, regeneration, and replacement of soft and hard tissue through its orthopaedics, sports medicine, and wound management divisions.